Lee Phan, DO
Interventional Cardiology · Brandon, FLNPI 1487005138
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.6%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 26.4% of the total. Reporting peaked in 2023 at $4,269 and has fallen 95.3% since, to $202 in 2025. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.
Across 77 payments — averaging $89.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Edwards Lifesciences$1K
- Medtronic$888
- Shockwave Medical, Inc$320
- Kestra Medical Technology Services, Inc.$228
- plus $404 from 7 others
What the payments were for
- Grants$1,64524%
- Travel & lodging$1,65024%
- Food & beverage$3,41550%
- Education$1763%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $1,820 |
| Abbott | 22 | $1,754 |
| Edwards Lifesciences | 12 | $1,473 |
| Medtronic | 23 | $888 |
| Shockwave Medical, Inc | 4 | $320 |
| Kestra Medical Technology Services, Inc. | 4 | $228 |
| Astellas Pharma US Inc | 2 | $175 |
| Abiomed | 1 | $109 |
| Philips North America LLC | 1 | $50 |
| Terumo Medical Corporation | 1 | $22 |
| Amgen | 1 | $20 |
| AbbVie | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,886 in reported general payments places this provider in the 45th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 78 | $94,551 |
| EntrestoSacubitril/Valsartan | 17 | $25,541 |
| BrilintaTicagrelor | 22 | $17,478 |
| Nitroglycerin | 20 | $472 |
| ClopidogrelClopidogrel Bisulfate | 36 | $368 |
| Atorvastatin Calcium | 29 | $269 |
| Metoprolol Tartrate | 32 | $226 |
| Metoprolol Succinate | 25 | $211 |
| Carvedilol | 15 | $100 |
| Furosemide | 20 | $60 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Brandon
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
- Miguel DiazHialeah$383K
- Douglas EbersoleLakeland$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.